Vial Welcomes Dr. Brian Rini of the Vanderbilt-Ingram Cancer Center (VICC) to their Oncology CRO Advisory Board

SAN FRANCISCO, Aug. 28, 2022 /PRNewswire/ -- Brian Rini, MD, is the Chief of Clinical Trials at Vanderbilt University and is recognized globally as a leader in genitourinary oncology, kidney cancer, and clinical drug development. Rini will join Vial's Oncology CRO Advisory Board as a...

Click to view original post